Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Return on Sales (2016 - 2025)

Firefly Neuroscience has reported Return on Sales over the past 15 years, most recently at 6.02% for Q4 2025.

  • Quarterly results put Return on Sales at 6.02% for Q4 2025, up 6532.0% from a year ago — trailing twelve months through Dec 2025 was 17.41% (up 5731.0% YoY), and the annual figure for FY2025 was 17.41%, up 7941.0%.
  • Return on Sales for Q4 2025 was 6.02% at Firefly Neuroscience, up from 6.8% in the prior quarter.
  • Over the last five years, Return on Sales for AIFF hit a ceiling of 0.11% in Q2 2022 and a floor of 300.7% in Q1 2025.
  • Median Return on Sales over the past 5 years was 1.37% (2023), compared with a mean of 29.41%.
  • Biggest five-year swings in Return on Sales: tumbled -12863bps in 2024 and later soared 12317bps in 2025.
  • Firefly Neuroscience's Return on Sales stood at 0.09% in 2021, then plummeted by -4588bps to 4.26% in 2022, then surged by 101bps to 0.03% in 2023, then plummeted by -264481bps to 71.34% in 2024, then soared by 92bps to 6.02% in 2025.
  • The last three reported values for Return on Sales were 6.02% (Q4 2025), 6.8% (Q3 2025), and 6.13% (Q2 2025) per Business Quant data.